Antifungal agents. Part I. Amphotericin B preparations and flucytosine

Mayo Clin Proc. 1998 Dec;73(12):1205-25. doi: 10.4065/73.12.1205.

Abstract

Traditionally, amphotericin B has been the cornerstone of antifungal treatment. Toxicity, however, is a major dose-limiting factor of amphotericin B deoxycholate. Nevertheless, it continues to have a major role in the treatment of deep-seated mycotic infections. Recently, less nephrotic lipid formulations, including amphotericin B lipid complex, amphotericin B cholesteryl sulfate, and liposomal amphotericin B, have been introduced. The pharmacologic properties, main indications, recommended dosages, related costs, and adverse effects of these various preparations are summarized in this review. Orally administered flucytosine is useful in certain infections, particularly cryptococcal meningitis, but it should be used with caution in patients with renal insufficiency.

Publication types

  • Review

MeSH terms

  • Amphotericin B / administration & dosage
  • Amphotericin B / pharmacology*
  • Antifungal Agents / administration & dosage
  • Antifungal Agents / pharmacology*
  • Drug Carriers
  • Flucytosine / administration & dosage
  • Flucytosine / pharmacology*
  • Humans
  • Liposomes

Substances

  • Antifungal Agents
  • Drug Carriers
  • Liposomes
  • Amphotericin B
  • Flucytosine